394 filings
Page 4 of 20
8-K
74nongtvogfa
11 Jan 21
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2020
7:00am
8-K
4fwy13 cqdnvv
5 Nov 20
AtriCure Reports Third Quarter 2020 Financial Results
4:07pm
8-K
usxmw9vlta
6 Aug 20
AtriCure Announces Angie Wirick as Chief Financial Officer
4:16pm
S-8
a5dqb
30 Jul 20
Registration of securities for employees
5:52pm
8-K
o92f1x1
28 Jul 20
AtriCure Reports Second Quarter 2020 Financial Results
4:03pm
SD
hyzel6a4ckjob
28 May 20
Conflict minerals disclosure
1:38pm
8-K
unbe az0dzsypy0emkdc
22 May 20
Departure of Directors or Certain Officers
11:46am
424B5
jzl7m k88t264n9y
13 May 20
Prospectus supplement for primary offering
12:00am
8-K
qikdevxmeu4xhrdp43
13 May 20
AtriCure Announces Proposed Public Offering of Common Stock
12:00am
424B5
14rxtw
11 May 20
Prospectus supplement for primary offering
7:58am
8-K
4v3to
8 May 20
AtriCure Announces Results from CONVERGE IDE Clinical Trial
8:55am
8-K
kvpzjvkuc 9z5f
29 Apr 20
AtriCure Reports First Quarter 2020 Financial Results
4:05pm
8-K
f8gaaruu75kob3d
13 Apr 20
AtriCure Announces CONVERGE IDE Trial Results Accepted for Late-Breaking Clinical Trial Sessions at Annual Heart Rhythm Society (HRS) Meeting
8:00am
8-K
k140lbjrn
9 Apr 20
AtriCure Announces Preliminary Financial Results for First Quarter 2020 and Provides COVID-19 Pandemic Update
8:00am
DEFA14A
uqp0mi9
8 Apr 20
Additional proxy soliciting materials
7:36am